Expert consensus on the use of corticosteroid in patients with 2019⁃nCoV pneumonia;新型冠状病毒肺炎糖皮质激素使用的建议

Zhonghua Jiehe he Huxi Zazhi / Chinese Journal of Tuberculosis and Respiratory Diseases

Volumn 43, Issue 3, 2020, Pages 183-184

  Zhao, Jianping ^a   Hu, Yi ^a   Du, Ronghui ^a   Chen, Zhenshun ^a   Jin, Yang ^a   Zhou, Min ^a   Zhang, Jing ^a   Qu, Jieming ^a   Cao, Bin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85177556118     PISSN: 10010939     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1001-0939.2020.03.008     Document Type: Note

References (9)

1. Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia[J]. Cochrane Database Syst Rev, 2017(12). DOI: 10.1002/14651858.CD007720.pub3.
2. Chen R, Tang X, Tan Y, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience[J]. Chest, 2006, 129(6): 1441‑1452. DOI: 10.1378/ chest.129.6.1441.
3. Auyeung TW, Lee JSW, Lai WK, et al. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study[J]. J Infection, 2005, 51(2): 98‑102. DOI: 10.1016/j.jinf.2004.09.008.
4. Lee N, Allen Chan KC, Hui DS, et al. Effects of early corticosteroid treatment on plasma SARS‑associated Coronavirus RNA concentrations in adult patients[J]. J Clin Virology, 2004, 31(4): 304‑309. DOI: 10.1016 / j. jcv. 2004.07. 006.
5. Arabi YM, Mandourah Y, Al‑Hameed F, et al. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome[J]. Am J Resp Crit Care Med, 2018, 197 (6): 757‑767. DOI: 10.1164/rccm.201706‑1172OC.
6. Alfaraj SH, Al‑Tawfiq JA, Assiri AY, et al. Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS‑CoV) infection: a cohort study[J]. Travel Med Infect Dis, 2019, 29: 48‑50. DOI: 10.1016/j.tmaid.2019.03.004.
7. Moreno G, Rodríguez A, Reyes LF, et al. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study[J]. Inte Care Med, 2018, 44(9): 1470‑1482. DOI: 10.1007/s00134‑018‑ 5332‑4.
8. Cao B, Gao H, Zhou B, et al. Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia[J]. Crit Care Med, 2016, 44(6): e318‑328. DOI: 10.1097/CCM.0000000000001616.
9. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019‑nCoV lung injury[J]. Lancet, 2020. DOI: 10.1016/S0140‑6736(20)30317‑2.